MIRVASO gel 3.3 mg/g tb 30 g
7680651800025
CH-65180
D11AX21
10.99.0.
Reimbursement limitations:
MIRVASO
Prescription initiale par un spécialiste en dermatologie et vénéréologie uniquement.
MIRVASO est remboursé uniquement à …
1 / 3
google
Details
- Product number
- 6518001
- CPT
- -
- Packaging group
- 30
- Unit
- g
- Composition
- brimonidinum 3.3 mg ut brimonidini tartras, propylenglycolum, conserv.: phenoxyethanolum, E 218, excipiens ad gelatum.
Articles (1)
Mirvaso 3.3mg/g, Gel
Gel
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
GEL
|
5.0 MG | Substance | WIZUS |
|
GEL
|
3.3 MG | Substance | Wirkstoff (Principe actif) |
|
GEL
|
- | Substance | HNIDK |
|
GEL
|
1.0 MG | Substance | HBESI |
|
GEL
|
- | Substance | Konservierungsstoff (Conservateur) |
|
GEL
|
- | Substance | HNIDK |
|
GEL
|
- | Substance | FNIDK |
|
GEL
|
55.0 MG | Substance | HBESI |
|
GEL
|
- | Substance | HNIDK |
|
GEL
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 57.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2015
Authorization holder
Galderma SA
6300 Zug
Authorization information
- Swissmedic authorization number
- 65180
- Drug name
- Mirvaso, Gel
- Galenic form
- GELK
- ATC Code
- D11AX21
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 21/11/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 10.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MIRVASO gel 3.3 mg/g tb 30 g
- Description (DE)
- MIRVASO Gel 3.3 mg/g Tb 30 g
- Market launch
- 21/11/2014
- Narcotic (BTM)
- No